Bristol Myers Squibb to Participate in the 2023 Jefferies London Healthcare Conference

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) to participate in 2023 Jefferies London Healthcare Conference, with Tim Power, VP of investor relations, addressing questions

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the 2023 Jefferies London Healthcare Conference in London, England, on Thursday, November 16, 2023. Tim Power, vice president, head of investor relations, will answer questions about the company during a fireside chat at 9:30 a.m. GMT (U.K.).

Investors and the general public are invited to listen to a live webcast of the session here. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20231109556813/en/

Media:

media@bms.com

Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

What event will Bristol Myers Squibb (NYSE: BMY) participate in?

Bristol Myers Squibb (NYSE: BMY) will participate in the 2023 Jefferies London Healthcare Conference in London, England.

Who will be representing Bristol Myers Squibb (NYSE: BMY) at the conference?

Tim Power, vice president and head of investor relations, will be addressing questions at the conference.